{"disease":{"id":"advanced-stage-solid-tumors","name":"advanced stage solid tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07223125","title":"A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03982303","title":"Phase I Study of Hemay102 in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":39,"lead_sponsor_name":"Tianjin Hemay Oncology Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06255665","title":"A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT02160106","title":"First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"MedPacto, Inc.","has_results":false},{"nct_id":"NCT03309150","title":"ATRi Transition Rollover Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Merck KGaA, Darmstadt, Germany","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}